{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:20:26Z","timestamp":1778934026203,"version":"3.51.4"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00320","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T16:00:41Z","timestamp":1551196841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Reversal of New Onset Type 1 Diabetes by Oral Salmonella-Based Combination Therapy and Mediated by Regulatory T-Cells in NOD Mice"],"prefix":"10.3389","volume":"10","author":[{"given":"Jacques C.","family":"Mbongue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Rawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Kandeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed I.","family":"Husseiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1172\/JCI200421307","article-title":"Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes","volume":"114","author":"Achenbach","year":"2004","journal-title":"J Clin Invest."},{"key":"B2","doi-asserted-by":"publisher","first-page":"a007641","DOI":"10.1101\/cshperspect.a007641","article-title":"The pathogenesis and natural history of type 1 diabetes","volume":"2","author":"Atkinson","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fimmu.2017.00327","article-title":"The role of dendritic cell maturation in the induction of insulin-dependent diabetes mellitus","volume":"8","author":"Mbongue","year":"2017","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ecl.2010.05.009","article-title":"Complications of type 1 diabetes","volume":"39","author":"Melendez-Ramirez","year":"2010","journal-title":"Endocrin Metab Clin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.2337\/db10-1201","article-title":"Defective differentiation of regulatory FoxP3(+) T cells by small-intestinal dendritic cells in patients with type 1 diabetes","volume":"60","author":"Badami","year":"2011","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/414792a","article-title":"beta-cell death during progression to diabetes","volume":"414","author":"Mathis","year":"2001","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJM198809083191002","article-title":"Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus","volume":"319","author":"Silverstein","year":"1988","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/MOT.0b013e32833f7114","article-title":"Negative vaccination by tolerogenic dendritic cells in organ transplantation","volume":"15","author":"Hill","year":"2010","journal-title":"Curr Opin Organ Tran."},{"key":"B10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fimmu.2015.00569","article-title":"Tolerogenic dendritic cells for regulatory T cell induction in man","volume":"6","author":"Raker","year":"2015","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1182\/blood-2011-08-377416","article-title":"Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4\/HLA-G pathway","volume":"118","author":"Gregori","year":"2011","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1074-7613(03)00113-4","article-title":"Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo","volume":"18","author":"Wakkach","year":"2003","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/cei.12691","article-title":"Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese 0diabetic mice","volume":"182","author":"Bellemore","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.0105-2896.2006.00414.x","article-title":"Regulatory T cells in the periphery","volume":"212","author":"Lohr","year":"2006","journal-title":"Immunol Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-662-43492-5","article-title":"Tr1 Cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm1014-1217c","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"20","author":"Gagliani","year":"2014","journal-title":"Nat Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.4049\/jimmunol.164.11.5583","article-title":"A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens","volume":"164","author":"El Mir","year":"2000","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.it.2003.10.001","article-title":"LAG-3:a regulator of T-cell and DC responses and its use in therapeutic vaccination","volume":"24","author":"Triebel","year":"2003","journal-title":"Trends Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.4049\/jimmunol.168.8.3874","article-title":"Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223)","volume":"168","author":"Andreae","year":"2002","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1172\/JCI19585","article-title":"Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health","volume":"113","author":"Arif","year":"2004","journal-title":"J Clin Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.4049\/jimmunol.1601045","article-title":"IL-10 receptor signaling is essential for T(R)1 cell function in vivo","volume":"198","author":"Brockmann","year":"2017","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1073\/pnas.1705599114","article-title":"Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development","volume":"114","author":"Yu","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2337\/db09-1168","article-title":"Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant","volume":"59","author":"Gagliani","year":"2010","journal-title":"Diabetes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijmm.2007.08.006","article-title":"Rational design of Salmonella recombinant vaccines","volume":"298","author":"Cheminay","year":"2008","journal-title":"Int J Med Microb"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.4049\/jimmunol.174.5.2892","article-title":"Intracellular Salmonella inhibit antigen presentation by dendritic cells","volume":"174","author":"Cheminay","year":"2005","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.4049\/jimmunol.177.4.2224","article-title":"Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes","volume":"177","author":"Raine","year":"2006","journal-title":"J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/ijc.24957","article-title":"Novel cancer vaccine based on genes of Salmonella pathogenicity island 2","volume":"126","author":"Xiong","year":"2010","journal-title":"Int J Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.vaccine.2004.11.035","article-title":"Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines","volume":"23","author":"Husseiny","year":"2005","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1128\/IAI.00298-10","article-title":"Efficacy of intracellular activated promoters for generation of Salmonella-based vaccines","volume":"78","author":"Xu","year":"2010","journal-title":"Infect Immun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.vaccine.2005.11.020","article-title":"Recombinant vaccines based on translocated effector proteins of Salmonella pathogenicity island 2","volume":"25","author":"Husseiny","year":"2007","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1128\/IAI.01066-08","article-title":"Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues","volume":"77","author":"Ashkar","year":"2009","journal-title":"Infect Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1128\/JCM.01255-07","article-title":"Salmonella enterica serovar Senftenberg human clinical isolates lacking SPI-1","volume":"46","author":"Hu","year":"2008","journal-title":"J Clin Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1172\/JCI28045","article-title":"In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines","volume":"116","author":"Nishikawa","year":"2006","journal-title":"J Clin Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1128\/JVI.77.4.2400-2409.2003","article-title":"Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system","volume":"77","author":"Evans","year":"2003","journal-title":"J Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.vaccine.2014.02.070","article-title":"An oral vaccine for type 1 diabetes based on live attenuated Salmonella","volume":"32","author":"Husseiny","year":"2014","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1016\/j.vaccine.2018.10.101","article-title":"Factors affecting Salmonella-based combination immunotherapy for prevention of type 1 diabetes in non-obese diabetic mice","volume":"36","author":"Husseiny","year":"2018","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.2337\/db13-1236","article-title":"Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice","volume":"63","author":"Robert","year":"2014","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1172\/JCI60530","article-title":"Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice","volume":"122","author":"Takiishi","year":"2012","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1084\/jem.20110574","article-title":"Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope","volume":"208","author":"Daniel","year":"2011","journal-title":"J Exp Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4(+)CD25(+) immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1034\/j.1600-065X.2001.1820105.x","article-title":"Type 1 T regulatory cells","volume":"182","author":"Roncarolo","year":"2001","journal-title":"Immunol Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00005-017-0482-6","article-title":"Role of TGF-beta in self-peptide regulation of autoimmunity","volume":"66","author":"Singh","year":"2018","journal-title":"Arch Immunol Ther Exp."},{"key":"B47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2337\/db05-1576","article-title":"Induction of tolerance in type 1 diabetes via both CD4(+) CD25(+) T regulatory cells and T regulatory type 1 cells","volume":"55","author":"Battaglia","year":"2006","journal-title":"Diabetes"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T16:00:42Z","timestamp":1551196842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2019.00320"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00320","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"article-number":"320"}}